CG Oncology (CGON) Stock Chart & Stock Price History → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CGON Stock Alerts $41.00 +4.80 (+13.26%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial Media CG Oncology Stock Price Performance5 Day Performance+12.92%1 Month Performance-6.61%3 Month Performance+17.04% Receive CGON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy CGON Stock Chart for Sunday, April, 28, 2024 CGON Chart by TradingView CG Oncology Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$36.20$41.00+13.26%$41.20$36.50819,590 shs$2.73 billion04/25/2024$36.05$36.20+0.42%$36.28$34.39183,717 shs$2.41 billion04/24/2024$36.31$36.05-0.72%$37.08$35.86292,352 shs$2.40 billion04/23/2024$33.54$36.31+8.26%$37.33$33.55422,621 shs$2.42 billion04/22/2024$35.34$33.54-5.09%$36.00$33.39278,123 shs$2.24 billion04/19/2024$35.32$35.34+0.06%$36.41$34.37197,472 shs$2.36 billion Get the Latest News and Ratings for CGON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$36.41$35.32-2.99%$37.05$34.90211,578 shs$2.35 billion04/17/2024$36.47$36.41-0.16%$37.17$35.68305,821 shs$2.43 billion04/16/2024$37.64$36.47-3.11%$37.63$35.62216,565 shs$2.43 billion04/15/2024$39.75$37.64-5.31%$39.74$36.92370,799 shs$2.51 billion04/12/2024$39.85$39.75-0.25%$40.11$38.74660,283 shs$2.65 billion04/11/2024$38.50$39.85+3.51%$40.07$38.19220,302 shs$2.66 billion04/10/2024$39.02$38.50-1.33%$38.56$37.29596,588 shs$2.57 billion04/09/2024$39.15$39.02-0.33%$39.96$38.81238,360 shs$2.60 billion04/08/2024$38.46$39.15+1.79%$40.17$38.10339,130 shs$2.61 billion04/05/2024$37.75$38.46+1.88%$39.01$37.46181,202 shs$2.56 billion04/04/2024$38.39$37.75-1.67%$39.51$37.48358,993 shs$2.52 billion04/03/2024$40.50$38.39-5.21%$40.37$38.00283,501 shs$2.56 billion04/02/2024$42.76$40.50-5.29%$42.43$40.24396,009 shs$2.70 billion04/01/2024$43.90$42.76-2.60%$44.26$42.35483,973 shs$2.85 billion03/29/2024$43.90$43.90$45.21$40.82747,532 shs$2.93 billion03/28/2024$41.00$43.90+7.07%$45.21$40.82747,462 shs$2.79 billion03/27/2024$40.87$41.00+0.32%$41.66$40.22295,033 shs$2.60 billion03/26/2024$40.76$40.87+0.27%$41.36$40.07425,497 shs$2.59 billion03/25/2024$40.50$40.76+0.64%$41.73$39.84284,131 shs$2.59 billion03/22/2024$41.12$40.50-1.51%$41.74$39.61800,150 shs$2.57 billion03/21/2024$39.05$41.12+5.30%$42.11$38.41619,652 shs$2.61 billion03/20/2024$39.70$39.05-1.64%$40.16$38.02432,822 shs$2.48 billion03/19/2024$38.11$39.70+4.17%$41.15$38.13677,990 shs$2.52 billion03/18/2024$38.52$38.11-1.06%$39.02$37.66449,345 shs$2.42 billion03/15/2024$37.20$38.52+3.55%$39.57$37.064.98 million shs$2.45 billion03/14/2024$39.79$37.20-6.51%$39.90$36.74729,544 shs$2.36 billion03/13/2024$35.67$39.79+11.55%$39.86$35.46622,301 shs$2.53 billion03/12/2024$35.00$35.67+1.91%$35.67$34.47828,167 shs$2.26 billion03/11/2024$35.51$35.00-1.44%$37.40$33.91915,905 shs$2.22 billion03/08/2024$39.86$35.51-10.91%$39.99$32.651.42 million shs$2.25 billion03/07/2024$42.79$39.86-6.85%$44.36$39.43430,273 shs$2.53 billion03/06/2024$41.49$42.79+3.13%$43.10$41.01441,143 shs$2.72 billion03/05/2024$43.09$41.49-3.71%$43.35$40.71528,848 shs$2.63 billion03/04/2024$43.98$43.09-2.02%$45.33$41.92602,420 shs$2.74 billionThese AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy03/01/2024$44.71$43.98-1.63%$46.53$42.39459,052 shs$2.79 billion02/29/2024$44.40$44.71+0.70%$47.78$44.21423,593 shs$2.84 billion02/28/2024$46.35$44.40-4.21%$47.76$43.81326,703 shs$2.82 billion02/27/2024$46.01$46.35+0.74%$46.95$44.81227,791 shs$2.94 billion02/26/2024$43.61$46.01+5.50%$46.73$43.40299,921 shs$2.92 billion02/23/2024$46.17$43.61-5.54%$47.93$42.12400,027 shs$2.77 billion02/22/2024$45.28$46.17+1.97%$47.31$44.85332,012 shs$2.93 billion02/21/2024$44.37$45.28+2.05%$46.98$43.51473,948 shs$2.87 billion02/20/2024$47.93$44.37-7.43%$48.60$44.13490,868 shs$2.82 billion02/19/2024$47.93$47.93$50.23$47.42361,300 shs$3.04 billion02/16/2024$47.46$47.93+0.99%$50.23$47.42361,349 shs$3.04 billion02/15/2024$43.42$47.46+9.30%$48.00$43.53494,829 shs$3.01 billion02/14/2024$44.18$43.42-1.72%$47.29$42.82384,186 shs$2.76 billion02/13/2024$43.74$44.18+1.01%$46.60$42.80522,316 shs$2.80 billion02/12/2024$41.57$43.74+5.22%$47.24$41.57660,519 shs$2.78 billion02/09/2024$39.02$41.57+6.54%$43.76$38.68575,603 shs$2.64 billion02/08/2024$40.52$39.02-3.70%$44.91$38.75657,262 shs$2.48 billion02/07/2024$37.03$40.52+9.42%$41.82$37.15759,683 shs$2.57 billion02/06/2024$37.42$37.03-1.04%$40.35$36.69639,461 shs$2.35 billion02/05/2024$35.81$37.42+4.50%$38.01$35.69189,889 shs$2.38 billion02/02/2024$37.95$35.81-5.64%$38.75$35.81394,098 shs$0.0002/01/2024$37.26$37.95+1.85%$40.68$36.11544,596 shs$0.0001/31/2024$36.50$37.26+2.08%$39.25$35.002.69 million shs$0.0001/30/2024$37.00$36.50-1.35%$39.70$35.521.19 million shs$0.0001/29/2024$35.03$37.00+5.62%$37.99$35.501.09 million shs$0.00 Related Companies: Denali Therapeutics Stock Chart Vericel Stock Chart Kymera Therapeutics Stock Chart Apogee Therapeutics Stock Chart Arcellx Stock Chart Immunocore Stock Chart Sana Biotechnology Stock Chart Beam Therapeutics Stock Chart Recursion Pharmaceuticals Stock Chart Fusion Pharmaceuticals Stock Chart Receive CGON Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGON) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.